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Dr June D Almeida (Royal Postgraduate Medical School, Hammersmith Hospital, London W12) Electron Microscope Findings in the Field ofSerum Hepatitis Direct electron microscopy of infected serum has shown that the serum hepatitis associated Australia antigen can be present either as individual particles or as aggregates having all the appearances of immune complexes (Almeida & Waterson 1969) . More recently it has been possible with the same technique to follow the course of the antigen in the serum of two patients who had prolonged attacks of serum hepatitis. The pattern was the same in both cases, the antigen first appearing unaggregated and randomly distributed, then becoming clumped and finally clearing from the circulation. A case of the disease in a member of staff exposed to risk allowed us, because of the precautionary procedure of bleeding possible contacts on a weekly basis, to establish that the Australia antigen could be seen in the serum a week before the illness appeared (Trowell etal. 1971) . The Australia Antigen in Chronic Active Hepatitis There are two main theories as to the cause of chronic active hepatitis, one that it is due to an autoimmune disturbance and the other that it is due to persistence of the hepatitis virus. The discovery of the Australia antigen and recognition of its close association with at least one of the infective agents responsible for acute viral hepatitis has enabled us to examine the second possibility. The frequency with which Australia antigen has been detected in chronic active hepatitis to date varies from nil to 25 % in reported series. The differences between the patients who have the Australia antigen in their serum and those in whom it was not detected have been reviewed and the results in 59 patients, which included 39 patients seen by the author at Yale and reported previously (Wright et al. 1969 ) and 20 additional patients seen at Oxford, have been analysed. The patients who had Australia antigen in their serum had a higher serum globulin and were more likely to have smooth muscle antibodies at high titre than the patients who did not have the antigen in their serum. Furthermore, epidemiological evidence of serum hepatitis at the onset was often present in those patients with the Australia antigen whose illness started acutely. It is suggested that because of the close association between Australia antigen and the agent responsible for serum hepatitis, the frequency with which the antigen is detected in chronic active hepatitis in a community will be related to the prevalence of serum hepatitis in that community. Chronic active hepatitis associated with the Australia antigen is very rarely seen in Great Britain. The only patient seen at Oxford with chronic active liver disease who had the Australia antigen in the serum was an infant who had acquired acute viral hepatitis, which progressed to cirrhosis, from her mother. Both mother and child had the antigen in their serum persistently. The mother became a chronic carrier with a normal liver biopsy whereas the infant developed cirrhosis associated with giant cells over a period of seven months following acute viral hepatitis. Both mother and child had striking tubular forms of the antigen and the large particles described by Dane et al. (1970) were detected frequently in the serum of the infant. It is concluded that although active chronic liver disease in association with the Australia antigen is rare in this country it does occur. It may, however, be a much more frequent cause of cirrhosis in tropical and subtropical communities where the antigen occurs frequently in the apparently healthy population.
The possibility that patients with chronic active hepatitis who have the Australia antigen in their serum and those who do not have the antigen might be etiologically distinct has been examined by studying the relationship of the Australia antigen to the smooth muscle antibody, an antibody frequently present in the serum of patients with chronic active hepatitis at high titre. Only one patient with chronic active hepatitis who had the Australia antigen in her serum also had the smooth muscle antibody at high titre, whereas it was frequently present in those who did not have the antigen. The significance of the smooth muscle antibody is uncertain but one possibility is that it could be related to an infective agent other than the Australia antigen. In order to examine this possibility sera from patients with acute viral hepatitis were tested for the smooth muscle antibody but this was detected as frequently in patients who had the Australia antigen in their serum as in those who did not have the antigen. It is concluded that there is strong evidence to indicate that chronic active hepatitis, which may progress to cirrhosis, can develop in association with the Australia antigen in the serum and that the antigen may be directly involved in its pathogenesis. This group of patients may differ etiologically from those with hyper-globulin&emia and immunological abnormalities including a positive LE cell phenomenon, antinuclear factor and high titre smooth muscle
